BusinessPhoto: Business StandardMorepen launches first US prescription generic drug
Morepen Laboratories, an Indian pharmaceutical company, launched its first prescription generic product, Desloratadine Tablets USP 5 mg, in the US market. The product is available in 100-count and 500-count packs through Morepen Bio Inc., its US subsidiary. This launch marks Morepen's entry into the US prescription generics segment, expanding from API supply to finished-dosage medicines and distribution.
Business Standard·



